Design, Synthesis and In Vitro Biological Assessment Of Novel 2-[(3-Alkyl/Aryl-4,5-Dihydro-1h-1,2,4-Triazol-5-One-4-Yl)Azomethine]Phenyl 2,5-Dichlorobenzenesulfonates Molecules as Antioxidant and Antibacterial Agents

Year 2025, Volume: 14 Issue: 3, 1453 - 1468, 30.09.2025

Fevzi Aytemiz , Haydar Yüksek

https://doi.org/10.17798/bitlisfen.1655093

Abstract

In this study, a total of nine new 2-[(3-alkyl/aryl-4,5-dihydro-1H-1,2,4-triazol-5-one-4-yl)azomethine]phenyl 2,5-dichlorobenzenesulfonates (4a-i) were synthesized through the reactions of 2-formylphenyl 2,5-dichlorobenzenesulfonate (3) with 3-alkyl(aryl)-4-amino-4,5-dihydro-1H-1,2,4-triazol-5-ones (2a-i). The compounds 4a, 4e, 4g and 4h were successfully synthesized with yields exceeding 90%. Compounds 4a-i were elucidated using 1H, 13C NMR and IR spectroscopic methods. The spectroscopic data were compared with the literature, and the results were found to be consistent. The antioxidant effects of compounds 4a–i were investigated using three different methods, and it was found that compounds 4a-i showed metal chelation activity close to that of α-tocopherol, which was used as the standard. Additionally, the antimicrobial properties of the compounds 4a–i were evaluated using the agar well diffusion method against six different bacterial strains. The antimicrobial properties of the new compounds (4a-i) were compared with those of standard antibiotics such as neomycin, streptomycin, and ampicillin. It was observed that compound 4a exhibited better antimicrobial activity than neomycin and streptomycin, and comparable activity to ampicillin.

Keywords

1,2,4-Triazol, , Synthesis , Antioxidant , Antibacterial

Ethical Statement

The study is complied with research and publication ethics.

Supporting Institution

Kafkas University Scientific Research Projects Coordination Unit

Project Number

2019-FM-09

Thanks

This study was supported by Kafkas University Scientific Research Projects Coordination Unit (Doctoral Thesis Project, Project Number: 2019-FM-09).

References

• S. Kahraman et al., ‘Copper(II) complexes with N,O-donor azo-Schiff base ligands: Synthesis, structure, DFT studies, molecular docking, anticancer and antimicrobial activity’, Polyhedron, vol. 269, p. 117393, Mar. 2025, doi: 10.1016/j.poly.2025.117393.
• M. Palaniappan et al., ‘Synthesis, characterization and biological evaluation of methyl dithiocarbonate-acenaphthenequinone (MDTCZ-ACQ) Schiff base ligand and its coordination complexes with copper, nickel, zinc, and cobalt’, Journal of the Indian Chemical Society, vol. 102, no. 3, p. 101615, Mar. 2025, doi: 10.1016/j.jics.2025.101615.
• M. A. Mir and B. K. Banik, ‘Synthesis of Schiff base ligands under environment friendly conditions: A systematic review’, Inorganic Chemistry Communications, vol. 174, p. 113987, Apr. 2025, doi: 10.1016/j.inoche.2025.113987.
• W. Jiang et al., ‘Copper-Catalyzed Cycloaddition/Coupling Cascades of Azomethine Imines with Alkynes for Divergent Synthesis of (Z)‑Alkenyl and Alkynyl N,N′-Bicyclic Pyrazolidinones’, Organic Letters, Dec. 2024, doi: 10.1021/acs.orglett.4c03824.
• Y. Sun, Y. Wang, L. Zhang, R. Zhong, and H. Wang, ‘Synthesis of Bridged and Fused Tetracycles via Rhodium‐Catalyzed C−H Allylation/Cycloaddition of Azomethine Imines with MBH Adducts and Allyl Acetates’, Asian Journal of Organic Chemistry, p. e202400646, Jan. 2025, doi: 10.1002/ajoc.202400646.
• Q. U. A. Sandhu, M. Pervaiz, A. Majid, U. Younas, Z. Saeed, A. Ashraf, and S. Jelani, “Schiff base metal complexes as anti-inflammatory agents,” Journal of Coordination Chemistry, cilt 76, sayı 9–10, ss. 1094–1118, 2023, doi: 10.1080/00958972.2023.2226794.
• R. P. Chinnasamy, R. Sundararajan, and S. Govindaraj, ‘Synthesis, characterization, and analgesic activity of novel Schiff base of isatin derivatives’, J Adv Pharm Technol Res, vol. 1, no. 3, pp. 342–347, 2010, doi: 10.4103/0110-5558.72428.
• K. Kar, D. Ghosh, B. Kabi, and A. Chandra, ‘A concise review on cobalt Schiff base complexes as anticancer agents’, Polyhedron, vol. 222, p. 115890, Aug. 2022, doi: 10.1016/j.poly.2022.115890.
• F. Aytemiz, ‘Synthesis, Characterization, and Investigation of Some Properties of Novel Heterocyclic Mannich Bases Containing the 4,5-Dihydro-1H-1,2,4-Triazol-5-one Ring’, Kafkas University, Faculty of Arts and Sciences, PhD Thesis 2020. [Online]. Available: https://acikbilim.yok.gov.tr/handle/20.500.12812/96651?show=full
• G. Hu et al., ‘Design, synthesis and antitumor activities of fluoroquinolone C-3 heterocycles (IV): s-triazole Schiff–Mannich bases derived from ofloxacin’, Acta Pharmaceutica Sinica B, vol. 2, no. 3, pp. 312–317, Jun. 2012, doi: 10.1016/j.apsb.2011.11.003.
• K. S. Kumar, S. Ganguly, R. Veerasamy, and E. De Clercq, ‘Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones’, European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 5474–5479, Nov. 2010, doi: 10.1016/j.ejmech.2010.07.058.
• I. Santos Oliveira et al., ‘Antibacterial and antifungal activities in vitro of a novel silver(I) complex with sulfadoxine-salicylaldehyde Schiff base’, Polyhedron, vol. 225, p. 116073, Oct. 2022, doi: 10.1016/j.poly.2022.116073.
• S. Mujeeb et al., ‘Chroman-Schiff base derivatives as potential Anti-Tubercular Agents: In silico studies, Synthesis, and Biological evaluation’, Bioorganic Chemistry, vol. 157, p. 108249, Apr. 2025, doi: 10.1016/j.bioorg.2025.108249.
• H. Yüksek, E. Koca, Ö. Gürsoy-Kol, O. Akyıldırım, and M. Çelebier, ‘Synthesis, in vitro antioxidant activity, and physicochemical properties of novel 4,5-dihydro-1H-1,2,4-triazol-5-one derivatives’, Journal of Molecular Liquids, vol. 206, pp. 359–366, Jun. 2015, doi: 10.1016/j.molliq.2015.02.038.
• R. Qurrat-ul-ain, M. Ur Rahman, H. M. Javed, S. Hassan, T. Munir, and R. Asghar, ‘Exploring sulfonamides derivatives Schiff base and metal complexes as antimicrobial agents: A comprehensive review’, Inorganic Chemistry Communications, vol. 170, p. 113396, Dec. 2024, doi: 10.1016/j.inoche.2024.113396.
• P. Meshram et al., ‘Design, synthesis and antibacterial activity of new Isatin-based Schiff base derivatives: Molecular docking, POM analysis, in silico pharmacokinetics and identification of antitumor pharmacophore sites’, Journal of Molecular Structure, vol. 1322, p. 140508, Feb. 2025, doi: 10.1016/j.molstruc.2024.140508.
• A. Shakoor et al., ‘Exploring the anti-diabetic activity of benzimidazole containing Schiff base derivatives: In vitro α-amylase, α-glucosidase inhibitions and in silico studies’, Journal of Molecular Structure, vol. 1321, p. 140136, Feb. 2025, doi: 10.1016/j.molstruc.2024.140136.
• H. Schiff, ‘Mittheilungen aus dem Universitätslaboratorium in Pisa: Eine neue Reihe organischer Basen’, Justus Liebigs Annalen der Chemie, vol. 131, no. 1, pp. 118–119, 1864, doi: 10.1002/jlac.18641310113.
• H. Yuksek et al., ‘Synthesis, potentiometric titrations and antioxidant activities of some 4-acylamino-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives’, Asian J. Chem., vol. 20, no. 7, pp. 5311–5321, Oct. 2008, Accessed: Nov. 28, 2022. [Online]. Available: https://www.webofscience.com/wos/woscc/full-record/WOS:000259602900051
• C. Öğretir, Y. Sıdır, İ. Sıdır, And E. Taşal, ‘Quantum chemical studies on tautomerism and basicity behavior of some 1,2,4-triazole derivatives’, Turkish Journal of Chemistry, vol. 34, no. 6, pp. 977–990, Jan. 2010, doi: 10.3906/kim-0904-31.
• P. Tyagi, S. Chandra, B. S. Saraswat, and D. Yadav, ‘Design, spectral characterization, thermal, DFT studies and anticancer cell line activities of Co(II), Ni(II) and Cu(II) complexes of Schiff bases derived from 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol’, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 145, pp. 155–164, Jun. 2015, doi: 10.1016/j.saa.2015.03.034.
• X. Li, X. Q. Li, H.-M. Liu, X.-Z. Zhou, and Z.-H. Shao, ‘Synthesis and evaluation of antitumor activities of novel chiral 1,2,4-triazole Schiff bases bearing γ-butenolide moiety’, Org Med Chem Lett, vol. 2, no. 1, p. 26, Jul. 2012, doi: 10.1186/2191-2858-2-26.
• O. Aktas-Yokus, H. Yuksek, O. Gursoy-Kol, and S. Alpay-Karaoglu, ‘Synthesis and biological evaluation of new 1,2,4-triazole derivatives with their potentiometric titrations’, Med. Chem. Res., vol. 24, no. 7, pp. 2813–2824, Jul. 2015, doi: 10.1007/s00044-015-1334-8.
• S. Sarkar, T. Mukherjee, S. Sen, E. Zangrando, and P. Chattopadhyay, ‘Copper(II) complex of in situ formed 5-(2-pyridyl)-1,3,4-triazole through C–S bond cleavage in 1,2-bis(2-pyridylmethylthio)-bis-ethylsulphide: Synthesis, structural characterization and DNA binding study’, Journal of Molecular Structure, vol. 980, no. 1–3, pp. 117–123, Sep. 2010, doi: 10.1016/j.molstruc.2010.07.002.
• A. Legru et al., ‘1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity’, European Journal of Medicinal Chemistry, vol. 226, p. 113873, Dec. 2021, doi: 10.1016/j.ejmech.2021.113873.
• S. Manap, F. Aytemiz, and H. Yuksek, “Synthesis and antioxidant activities of some novel 1-(morpholine-4-il-methyl)-3-alkyl(aryl)-4-(3-methoxy-4-isobutyryloxy)benzylideneamino-4,5-dihydro-1H-1,2,4-triazol-5-ones,” The Eurasia Proceedings of Science, Technology, Engineering and Mathematics, no. 2, pp. 135–142, 2018.
• P. Martins et al., ‘Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box’, Molecules, vol. 20, no. 9, pp. 16852–16891, Sep. 2015, doi: 10.3390/molecules200916852.
• I. Khan et al., ‘Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives’, European Journal of Medicinal Chemistry, vol. 45, no. 11, pp. 5200–5207, Nov. 2010, doi: 10.1016/j.ejmech.2010.08.034.
• J. Xu et al., ‘Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives’, European Journal of Medicinal Chemistry, vol. 46, no. 7, pp. 3142–3148, Jul. 2011, doi: 10.1016/j.ejmech.2011.02.042.
• J. Wu et al., ‘Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives’, European Journal of Medicinal Chemistry, vol. 143, pp. 1840–1846, Jan. 2018, doi: 10.1016/j.ejmech.2017.10.081.
• A. Espinel-Ingroff, ‘Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi’, Journal of Clinical Microbiology, vol. 39, no. 4, pp. 1360–1367, Apr. 2001, doi: 10.1128/jcm.39.4.1360-1367.2001.
• J. N. Galgiani, ‘Fluconazole, a New Antifungal Agent’, Ann Intern Med, vol. 113, no. 3, pp. 177–179, Aug. 1990, doi: 10.7326/0003-4819-113-3-177.
• R. C. Lin, N. Sanduja, and S. M. Hariprasad, ‘Successful Treatment of Postoperative Fungal Endophthalmitis Using Intravitreal and Intracameral Voriconazole’, Journal of Ocular Pharmacology and Therapeutics, vol. 24, no. 2, pp. 245–248, Apr. 2008, doi: 10.1089/jop.2007.0105.
• By El-Shorief, A. M. S., Ammar, M. S., Ammar, Y. A. and Zaki, M. E. A. ‘2,5-Dichlorobenzenesulfonamide derivatives and their biological activities’, Indian Journal of Chemistry, 22B(7), 700-4, 1983.
• A. A. Ikizler and H. Yüksek, ‘Acetylation of 4-amıno-4-dihydro-1H-1,2,4-triazol-5-ones’, Organic Preparations and Procedures International, Feb. 1993, doi: 10.1080/00304949309457935.
• T. Dinis, V. Madeira, and L. Almeida, ‘Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid-peroxidation and as peroxyl radical scavengers’, Archives of Biochemistry and Biophysics, vol. 315, pp. 161–169, 1994.
• M. Oyaizu, ‘Antioxidative activities of browning reaction prepared from glucosamine.’, Jpn. J. Nutr., vol. 44, no. 6, pp. 307–315, 1986, doi: 10.5264/eiyogakuzashi.44.307.
• M. S. Blois, ‘Antioxidant Determinations by the Use of a Stable Free Radical’, Nature, vol. 181, no. 4617, Art. no. 4617, Apr. 1958, doi: 10.1038/1811199a0.
• C. Erhonyota, G. I. Edo, and F. O. Onoharigho, ‘Comparison of poison plate and agar well diffusion method determining the antifungal activity of protein fractions’, Acta Ecologica Sinica, vol. 43, no. 4, pp. 684–689, Aug. 2023, doi: 10.1016/j.chnaes.2022.08.006.
• S. M. Mirtaghi, P. T. Nejad, M. Masoumeh Mazandarani, F. Livani, and H. Bagheri, ‘Evaluation of Antibacterial Activity of Urtica dioica L. Leaf Ethanolic Extract Using Agar Well Diffusion and Disc Diffusion Methods.’, Medical Laboratory Journal, vol. 10, no. 5, pp. 15–21, Sep. 2016, doi: 10.18869/acadpub.mlj.10.5.15.
• H. Gökce, O. Akyildirim, S. Bahçeli, H. Yüksek, and Ö. G. Kol, ‘The 1-acetyl-3-methyl-4-[3-methoxy-4-(4-methylbenzoxy)benzylidenamino]-4,5-dihydro-1H-1,2,4-triazol-5-one molecule investigated by a joint spectroscopic and quantum chemical calculations’, Journal of Molecular Structure, vol. 1056–1057, pp. 273–284, Jan. 2014, doi: 10.1016/j.molstruc.2013.10.044.
• P. K. Verma, M. Kumar, N. Malik, P. Dhiman, and A. Khatahar, ‘Design, Synthesis, Antimicrobial, and Antioxidant Activities of Novel-{4, 5-(substituted diphenyl)-4H-1, 2, 4-triazol-3-ylthio} Acetyl Chloride’, Walailak Journal of Science and Technology (WJST), vol. 15, no. 2, Art. no. 2, 2018, doi: 10.48048/wjst.2018.2178.
• M. Alkan et al., ‘Synthesis and Antioxidant and Antibacterial Activities of Novel 4-({[3-Alkyl(aryl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-4-yl]imino}­methyl)phenyl 4-Nitrobenzoate Derivatives’, Russ J Org Chem, vol. 58, no. 12, pp. 1839–1850, Dec. 2022, doi: 10.1134/S1070428022120132.